Related Experiment Video
Updated: May 22, 2026

Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
Iatrogenic Creutzfeldt-Jakob disease, final assessment
Paul Brown1, Jean-Philippe Brandel, Takeshi Sato
1Centre à l’Energie Atomique, Fontenay-aux-Roses, France. paulwbrown@comcast.net
Abstract:
The era of iatrogenic Creutzfeldt-Jakob disease (CJD) has nearly closed; only occasional cases with exceptionally long incubation periods are still appearing. The principal sources of these outbreaks are contaminated growth hormone (226 cases) and dura mater grafts (228 cases) derived from human cadavers with undiagnosed CJD infections; a small number of additional cases are caused by neurosurgical instrument contamination, corneal grafts, gonadotrophic hormone, and secondary infection with variant CJD transmitted by transfusion of blood products. No new sources of disease have been identified, and current practices, which combine improved recognition of potentially infected persons with new disinfection methods for fragile surgical instruments and biological products, should continue to minimize the risk for iatrogenic disease until a blood screening test for the detection of preclinical infection is validated for human use.
Related Concept Videos
Hepatic Encephalopathy
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Encephalitis ll: Pathophysiology
Pneumonia III: Complications and Assessment
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
